Amodiaquine for COVID-19

Maintained by Philip Neustrom
Edit

Amodiaquine, an antimalarial discovered in 1948, has been proposed as a possible treatment for COVID-19.

In a manuscript published on August 19, 2020, researchers showed that amodiaquine may have in vitro as well as in vivo activity against SARS-CoV-2.  Unlike hydroxycholorquine, another antimalarial, amodiaquine showed in vivo activity in hamsters.

See also

Edit
Contributed by
Except where otherwise noted, text content is licensed under a Creative Commons Attribution-ShareAlike License. See copyright information.